Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Blocking both P-cadherin and c-Met can effectively stop head and neck cancer growth.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Sema3A can both slow and speed up wound healing, depending on its form and combination with EGF.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Gray hair can potentially be reversed, leading to new treatments.

Androgens increase growth factors in skin cells, which may lead to acne.

Synthetic ceramides may help hair growth by boosting cell growth in hair follicles.

3D culture helps maintain hair growth cells better than 2D culture and identifies key genes for potential hair loss treatments.

Platycladi Cacumen may help treat hair loss by targeting specific proteins and pathways.

Blocking Wnt/β-catenin signaling with EGF receptor is necessary for proper hair growth.

Targeted cancer therapies often cause serious skin problems that need careful management.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Activating TRPV4 in skin cells helps regrow hair in mice, possibly offering a treatment for hair loss.

The enzyme PA-PLA1α is important for proper hair follicle development.

Removing Gsdma1/2/3 genes reduces skin cell overgrowth by blocking a specific cell pathway.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

ERK activation spreads between cells, influencing cell division and wound healing.

Nilotinib can cause generalized keratosis pilaris.

Hejie Shengfa Decoction may help treat alopecia areata by promoting hair growth and reducing inflammation, but more safety studies are needed.

IGF-1 can help regrow hair and may be a promising treatment for hair loss.

ERK activation spreads between cells in mouse skin, linked to cell division and influenced by TPA and EGF receptors.

Lupeol shows promise for hair growth but needs better absorption and safety testing.